SCHEMBL30241391

SCHEMBL30241391

C=CC(=O)Nc1ccc2c(ccn2Cc2cccc(OC)c2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 2/20 0.56
▸ NTSR1 P30989 1/20 0.52
▸ ERBB2 P04626 1/20 0.51
▸ HDAC8 Q9BY41 3/20 0.50
▸ HDAC6 Q9UBN7 3/20 0.50
▸ HDAC3 O15379 2/20 0.50
▸ HDAC1 Q13547 2/20 0.50
▸ HDAC2 Q92769 2/20 0.50
▸ HDAC10 Q969S8 2/20 0.50
▸ PTGER3 P43115 3/20 0.49
▸ TGM2 P21980 1/20 0.47
▸ MAOB P27338 1/20 0.46
▸ HDAC11 Q96DB2 2/20 0.46
▸ HDAC4 P56524 1/20 0.46
▸ HDAC7 Q8WUI4 1/20 0.46
▸ HDAC9 Q9UKV0 1/20 0.46
▸ HDAC5 Q9UQL6 1/20 0.46
▸ JAK3 P52333 2/20 0.46
▸ BTK Q06187 1/20 0.46
▸ ITK Q08881 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23902647 1.00 EGFR (0.56) EGFRNTSR1ERBB2HDAC8HDAC6
SCHEMBL23902658 0.88 EGFR (0.55) EGFRNTSR1ERBB2HDAC8HDAC6
SCHEMBL30241341 0.88 EGFR (0.55) EGFRNTSR1ERBB2HDAC8HDAC6
SCHEMBL30241492 0.87 EGFR (0.58) EGFRERBB2HDAC8HDAC6HDAC3
SCHEMBL23902694 0.87 EGFR (0.58) EGFRERBB2HDAC8HDAC6HDAC3
SCHEMBL23902645 0.86 ERBB2 (0.60) EGFRERBB2HDAC8HDAC6HDAC3
SCHEMBL30241481 0.86 ERBB2 (0.60) EGFRERBB2HDAC8HDAC6HDAC3
SCHEMBL30241436 0.85 EGFR (0.58) EGFRERBB2HDAC8HDAC6HDAC3
SCHEMBL23902656 0.85 EGFR (0.58) EGFRERBB2HDAC8HDAC6HDAC3
SCHEMBL30241403 0.84 EGFR (0.55) EGFRERBB2HDAC8HDAC6HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115667216-B (1H-indol-5-yl) acrylamide derivatives as inhibitors of TEAD proteins and HIPPO-YAP1/TAZ signaling cascades for the treatment of cancer 赛诺菲 2025-02-18 — — CN claimed
EP-4132907-A1 (1 H-INDOL-5-YL)ACRYLAMIDE DERIVATIVES AS INHIBITORS OF TEAD PROTEINS AND THE HIPPO-YAP1/TAZ SIGNALING CASCADE FOR THE TREATMENT OF CANCER SANOFI (FR) 2023-02-15 — — EP claimed
CN-115667216-A (1H-indol-5-yl) acrylamide derivatives as TEAD proteins and inhibitors of the HIPPO-YAP1/TAZ signaling cascade for the treatment of cancer 赛诺菲 2023-01-31 — — CN claimed
CN-115667216-B (1H-indol-5-yl) acrylamide derivatives as inhibitors of TEAD proteins and HIPPO-YAP1/TAZ signaling cascades for the treatment of cancer 赛诺菲 2025-02-18 — — CN disclosed
EP-4132907-A1 (1 H-INDOL-5-YL)ACRYLAMIDE DERIVATIVES AS INHIBITORS OF TEAD PROTEINS AND THE HIPPO-YAP1/TAZ SIGNALING CASCADE FOR THE TREATMENT OF CANCER SANOFI (FR) 2023-02-15 — — EP disclosed
CN-115667216-A (1H-indol-5-yl) acrylamide derivatives as TEAD proteins and inhibitors of the HIPPO-YAP1/TAZ signaling cascade for the treatment of cancer 赛诺菲 2023-01-31 — — CN disclosed
Send feedback